Acadian Asset Management LLC Clearside Biomedical, Inc. Transaction History

Acadian Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.82 - $1.27 $13,635 - $21,118	-16,629 Reduced 48.67%	17,536 $15,000
Q2 2023 Aug 07, 2023	SELL	$0.97 - $1.48 $99,964 - $152,522	-103,056 Reduced 75.1%	34,165 $37,000
Q4 2022 Feb 14, 2023	BUY	$1.0 - $1.5 $105,422 - $158,133	105,422 Added 331.53%	137,221 $152,000
Q3 2022 Nov 14, 2022	SELL	$1.08 - $1.83 $3,816 - $6,467	-3,534 Reduced 10.0%	31,799 $35,000
Q2 2022 Aug 09, 2022	BUY	$1.3 - $2.49 $45,932 - $87,979	35,333 New	35,333 $51,000

13.4M

17.6K

100

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.